Pharmacology News

Individuals who used or abused opioids were significantly more likely to receive sedating medications, including benzodiazepines, than those who did not use opioids, data show.

Nitrates were the most frequent cause of medication-induced headaches, according to an analysis of more than 2.6 million records in the FDA’s Adverse Event Reporting System.

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.

Patients with migraine who took calcitonin gene-related peptide-targeted monoclonal antibody therapy in combination with onabotulinumtoxinA had fewer monthly headache days and less migraine-related disability, according to researchers.

Children with substantial externalizing symptoms who received ADHD medications had lower odds for suicidality, a cohort study showed.

Most buprenorphine treatment provided in the U.S. was prescribed by a small proportion of clinicians, an analysis of retail pharmacy records showed.

Thirty-five percent of adults in the United States who were surveyed said they would consider leaving their primary care physician for qualified physicians providing on-demand telehealth services.

Nearly 1 in 5 adults with elevated BP also take a medication that could be raising their BP, according to a presentation at the American College of Cardiology Scientific Session.

In this video, Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania Perelman School of Medicine, addresses concerns that treatments for psoriatic disease could increase patients’ risk for COVID-19 infection or severe illness.